Bank Of Montreal Bio Xcel Therapeutics, Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.14 - $2.97 $12,311 - $32,076	-10,800 Reduced 25.65%	31,308 $40,000
Q1 2024 May 13, 2024	SELL	$1.95 - $4.04 $4,664 - $9,663	-2,392 Reduced 5.38%	42,108 $118,000
Q4 2023 Feb 08, 2024	BUY	$2.32 - $5.51 $4,408 - $10,469	1,900 Added 4.46%	44,500 $131,000
Q3 2023 Nov 01, 2023	BUY	$2.49 - $11.85 $106,074 - $504,810	42,600 New	42,600 $107,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.